In a way your semi-correct, this 3x revenue correction was likely written in collaboration with Locust Walk and sent out to all prospective partners IPIX found before Locust Walk came in play and those current prospective partners from Locust Walk interactions and other possibilities Locust Walk is looking for,to strengthen their hand in negotiations.
This is a competitor vs. competitor market analysis valuation, necessary for the accurate determination of valuing financial terms within the negotiations.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links